Zotepine is available in India as tablets of 25 mg, 50 mg and 100 mg strength, as recorded by the Central Drugs Standard Control Organisation (CDSCO). It belongs to a group of medicines called atypical (second-generation) antipsychotics and is chemically classed as a dibenzothiepine. Zotepine is prescribed mainly for schizophrenia, a long-term mental health condition that affects how a person thinks, feels, and behaves. It works by acting on several brain chemical messenger systems, particularly dopamine and serotonin, to help reduce symptoms such as hallucinations, delusions, and disorganised thinking. Zotepine has been used as an antipsychotic in Japan, Germany, and India for several decades, though it does not have marketing approval in the United States. It is meant to be taken only under the supervision of a psychiatrist, with the dose and duration decided based on the individual's response and tolerability.
Zotepine is an atypical antipsychotic that belongs to the dibenzothiepine chemical class. Unlike older, typical antipsychotics that mainly block dopamine receptors, Zotepine acts on a broader set of brain receptors. This gives it a distinct effect profile and is thought to lower the chance of certain movement-related side effects compared with older antipsychotic medicines, although this risk is not eliminated.
Zotepine is mainly prescribed for schizophrenia, a psychiatric condition where a person's thinking, emotions, and behaviour are affected, often leading to hallucinations, delusions, and difficulty functioning in daily life. By calming overactive signalling in certain brain pathways, Zotepine helps reduce these symptoms over time. It does not act instantly; most people need several weeks of consistent use before the full benefit is seen.
Zotepine tablets are manufactured in three strengths in India, 25 mg, 50 mg, and 100 mg, allowing the treating doctor to adjust the amount taken based on how a person responds and how well they tolerate the medicine. Because Zotepine affects the brain's chemical balance broadly, it needs regular medical supervision throughout treatment. This includes monitoring for movement-related side effects, changes in heart rhythm, blood sugar and cholesterol levels, and general mental state. Zotepine should never be started, stopped, or changed in dose without medical advice, since sudden changes can affect both symptom control and safety. People with a history of seizures, heart rhythm problems, liver disease, or certain other medical conditions need special caution and closer monitoring while taking this medicine, as described further in the sections below.
Common Side Effects (Usually Mild and May Lessen With Continued Use)
Serious Side Effects (Seek Urgent Medical Attention)
Zotepine tablets are usually taken by mouth, generally in divided doses through the day as directed by the doctor. The tablet should be swallowed whole with a glass of plain water; it should not be crushed, chewed, or broken unless the doctor or pharmacist has specifically said this is acceptable for a particular brand. Zotepine may be taken with or without food, but it is helpful to be consistent, taking it the same way and around the same time each day, since this helps maintain a steady level of the medicine in the body. It is important to complete the full course exactly as prescribed and to keep taking the medicine even once symptoms improve, because stopping suddenly or skipping doses can cause symptoms to return or lead to withdrawal-type effects. Any decision to stop or change how Zotepine is taken should be made together with the prescribing doctor.
Zotepine works mainly by blocking dopamine receptors (particularly the D2 type) in certain areas of the brain, which helps reduce overactive dopamine signalling that is linked to hallucinations and delusions in schizophrenia. In simple terms, dopamine is a chemical messenger in the brain, and too much activity in certain dopamine pathways is thought to drive some psychotic symptoms.
What sets Zotepine apart from older antipsychotic medicines is that it does not act on dopamine alone. It also blocks serotonin receptors (mainly the 5-HT2A type), another chemical messenger system, which is thought to help with negative symptoms like low motivation and social withdrawal, and may lower the risk of some movement-related side effects compared with medicines that only block dopamine. In addition, Zotepine blocks histamine (H1) receptors, which can contribute to sleepiness, and alpha-adrenergic receptors, which can contribute to a drop in blood pressure on standing. It also blocks the reuptake of noradrenaline, another chemical messenger, back into nerve cells, which may add to its overall effect on mood and alertness. Because Zotepine acts on this wider set of receptors rather than one single target, its effects and its side-effect pattern are broader than a simple dopamine-blocking medicine.
Zotepine should be used in pregnancy only if the treating doctor decides that the possible benefit clearly outweighs the possible risk, and only under specialist supervision. Do not start or stop this medicine during pregnancy without medical advice.
There is limited published information on how much Zotepine passes into breast milk. As a general precaution taken with psychiatric medicines during breastfeeding, it should be used only if advised by a doctor after weighing the benefits and risks for both mother and baby.
Alcohol can add to the sleepiness and dizziness caused by Zotepine and is best avoided during treatment.
Zotepine can cause drowsiness, dizziness, or blurred vision, so driving or operating heavy machinery should be avoided until it is known how the medicine affects the individual.
People with kidney problems should use Zotepine with caution and under closer medical supervision, as dose adjustment may be needed.
Zotepine is broken down in the liver, so it should be used cautiously in people with liver disease, and liver function may need to be monitored during treatment.
The safety and appropriate use of Zotepine in children has not been well studied, so it should only be used in this age group if specifically advised by a specialist.
Elderly patients, particularly those with dementia-related behavioural symptoms, are more sensitive to the sedative effects of Zotepine and to orthostatic hypotension (a drop in blood pressure on standing up that can cause dizziness or fainting), and are also at higher risk of falls as a result. Antipsychotic medicines as a class, including atypical antipsychotics like Zotepine, carry a known risk of increased mortality when used in elderly patients with dementia-related psychosis, so use in this group needs careful specialist assessment.
Store Zotepine tablets at room temperature, generally below 25 degrees C (77 degrees F), in a cool, dry place away from direct sunlight and moisture. Keep the medicine in its original container, away from the reach and sight of children and pets.
No specific major food interactions have been established for Zotepine in the available reference material. As a general precaution, it is best to maintain a consistent pattern of taking the medicine with regard to meals, and to avoid alcohol, since alcohol can increase drowsiness and dizziness caused by Zotepine.
Zotepine is generally given in divided doses through the day, and published clinical studies have used total daily doses in the range of about 75 mg to 450 mg. The exact dose, frequency, and duration must always be decided by the treating doctor based on the individual's diagnosis, response, and tolerability, and should never be changed without medical advice.
Signs of a Zotepine overdose can include severe drowsiness, marked dizziness, fainting, a rapid or irregular heartbeat, severe muscle stiffness, and seizures. An overdose is a medical emergency, and the affected person should be taken to the nearest hospital or emergency department immediately for evaluation and supportive treatment.
If a dose of Zotepine is missed, take it as soon as it is remembered, unless it is almost time for the next scheduled dose. In that case, skip the missed dose and continue with the regular dosing schedule. Do not take two doses together to make up for a missed one.
Contact your doctor promptly if you notice any of the following while taking Zotepine:
Therapeutic Class
Antipsychotic (used for schizophrenia and related psychotic disorders)
Action Class
Atypical (second-generation) antipsychotic; dopamine (D2) and serotonin (5-HT2A) receptor antagonist
Chemical Class
Dibenzothiepine
Habit Forming
No
Checkout Editorial Policy
Top Selling Medicines
Top Health Products
Top Selling Devices
Zotepine 50mg

₹77

Zotepine 50mg

₹79.2

Zotepine 50mg

₹79.2

Zotepine 25mg

₹59.5

Zotepine 25mg

₹56

Zotepine 100mg

₹118

Zotepine 100mg

₹110.2

Zotepine 50mg

₹69.4

Zotepine 25mg

₹45.9
